TERN
Terns Pharmaceuticals Inc

2,248
Mkt Cap
$2.44B
Volume
3.4M
52W High
$28.25
52W Low
$1.87
PE Ratio
-26.28
TERN Fundamentals
Price
$26.11
Prev Close
$27.12
Open
$27.20
50D MA
$11.28
Beta
1.06
Avg. Volume
1.66M
EPS (Annual)
-$1.12
P/B
8.35
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Terns Pharmaceuticals (NASDAQ:TERN) Price Target Raised to $35.00 at Truist Financial
Truist Financial increased their price objective on shares of Terns Pharmaceuticals from $28.00 to $35.00 and gave the stock a "buy" rating in a research report on Wednesday...
MarketBeat·5h ago
News Placeholder
More News
News Placeholder
Terns Pharmaceuticals (NASDAQ:TERN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says
BMO Capital Markets increased their price target on Terns Pharmaceuticals from $22.00 to $30.00 and gave the company an "outperform" rating in a research report on Tuesday...
MarketBeat·1d ago
News Placeholder
Terns Pharmaceuticals (NASDAQ:TERN) Hits New 1-Year High - Here's What Happened
Terns Pharmaceuticals (NASDAQ:TERN) Hits New 52-Week High - Time to Buy...
MarketBeat·2d ago
News Placeholder
Candriam S.C.A. Boosts Stock Holdings in Terns Pharmaceuticals, Inc. $TERN
Candriam S.C.A. raised its position in shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN - Free Report) by 9.9% in the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·5d ago
News Placeholder
Terns Pharmaceuticals (NASDAQ:TERN) Trading Up 9.6% on Analyst Upgrade
Terns Pharmaceuticals (NASDAQ:TERN) Trading Up 9.6% on Analyst Upgrade...
MarketBeat·5d ago
News Placeholder
Terns Pharmaceuticals (NASDAQ:TERN) Price Target Raised to $33.00 at Mizuho
Mizuho raised their target price on Terns Pharmaceuticals from $32.00 to $33.00 and gave the stock an "outperform" rating in a research note on Thursday...
MarketBeat·6d ago
News Placeholder
What is HC Wainwright's Forecast for TERN FY2025 Earnings?
Terns Pharmaceuticals, Inc. (NASDAQ:TERN - Free Report) - Investment analysts at HC Wainwright raised their FY2025 EPS estimates for shares of Terns Pharmaceuticals in a research report issued to...
MarketBeat·6d ago
News Placeholder
Terns Pharmaceuticals (NASDAQ:TERN) Issues Quarterly Earnings Results
Terns Pharmaceuticals (NASDAQ:TERN - Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.27) EPS for the quarter, topping the consensus estimate of ($0.32) by...
MarketBeat·9d ago
News Placeholder
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Average Rating of "Moderate Buy" by Analysts
Terns Pharmaceuticals, Inc. (NASDAQ:TERN - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eleven research firms that are covering the stock, MarketBeat Ratings...
MarketBeat·10d ago
News Placeholder
Terns Pharmaceuticals (NASDAQ:TERN) Reaches New 1-Year High After Earnings Beat
Terns Pharmaceuticals (NASDAQ:TERN) Reaches New 52-Week High on Better-Than-Expected Earnings...
MarketBeat·10d ago

Latest TERN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.